National Peroxide Limited is a Chemicals & Petrochemicals company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
| ₹ crore · consolidated | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | 333 | 287 | 290 |
| EBITDA (ex other income) | 38 | 15 | 31 |
| margin % | 11.3 | 5.3 | 10.6 |
| Owners' profit | 17 | (2) | 11 |
| EPS, as reported (₹) | 29.22 | 3.91 | 19.20 |
| ROE % · ROCE % | 4.7 · 5.6 | (0.6) · (0.1) | 3.0 · 3.8 |
| Debt / equity (x) | 0.03 | 0.01 | 0.01 |
| Cash from operations | 36 | 19 | 34 |
| Capex | (15) | (5) | (4) |
| ₹ crore | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 77 | 62 | 74 | 67 | 68 | 69 | 86 | 96 |
| Profit before tax | 1 | (2) | (8) | 1 | 1 | 2 | 11 | 9 |
| Net profit | 1 | (2) | (6) | 1 | 0 | 2 | 8 | 7 |
| EPS (₹) | 1.18 | (2.64) | 11.29 | 1.55 | 0.67 | 3.19 | 13.80 | 11.50 |
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| DEEPAK FERTILIZERS & PETR | 16,727 | 17.0 | 2.24 | 12.2 | 9.9 | 8.4 | 14.6 | 26.1 |
| TATA CHEMICALS LTD | 15,683 | — | 0.71 | 141.2 | (7.7) | (5.0) | 7.4 | 14.4 |
| GUJ NAR VAL FER & CHEM L | 8,273 | 8.0 | 0.91 | 6.0 | 8.9 | 10.3 | 8.7 | 22.1 |
| TANFAC INDUSTRIES LTD. | 6,773 | 55.4 | 18.15 | — | 18.8 | 24.3 | — | 16.0 |
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 5 Sept 2026 · National Peroxide 6th AGM notice published; final dividend Rs 7 per share | compliance | minimal | — | — |
| 4 Sept 2026 · TDS Communication on FY26 Dividend of Rs. 7 per Share | corporate actions | medium | — | — |
| 3 Sept 2026 · 6th AGM on Sep 29 2026 with Annual Report FY25-26 weblink to shareholders | board shareholder meetings | low | — | — |
| 3 Sept 2026 · National Peroxide 6th AGM notice with FY26 annual report; Rs 7 dividend recommended | board shareholder meetings | medium | — | — |
| 3 Sept 2026 · Annual Report FY 2025-26 and 6th AGM Notice | board shareholder meetings | medium | — | — |
| 1 Sept 2026 · AGM notice published; Rs 7 dividend recommended | compliance | minimal | — | — |
| 13 Aug 2026 · Revised audited FY26 and Q1 FY27 results published in newspapers | compliance | minimal | — | — |
| 12 Aug 2026 · Restated FY26 results, Rs 7 dividend, Q1 FY27 results approved | results | critical | — | — |
| 12 Aug 2026 · Board okays restated FY26 results, Q1 FY27; dividend Rs 7/share; AGM Sep 29 | results | critical | — | — |
| 12 Aug 2026 · National Peroxide restates FY26 results, cuts PAT by about 47%, retains Rs 7 dividend | results | high | — | — |
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions |
| GUJARAT ALKALIES & CHEM |
| 5,179 |
| 78.0 |
| 1.00 |
| 10.7 |
| (0.0) |
| 0.7 |
| 12.4 |
| 18.4 |
| GHCL LIMITED | 3,879 | 8.4 | 1.09 | 5.1 | 13.3 | 16.6 | 1.1 | 23.9 |
| GRAUER & WEIL IND LTD | 3,469 | 21.2 | 3.21 | 14.1 | 15.2 | 19.2 | 14.5 | 20.4 |
| J.G.CHEMICALS LIMITED | 2,330 | 31.0 | 4.31 | 23.7 | 12.7 | 16.9 | — | 11.5 |
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/E (TTM) | 21.6 | 17.0 | 37 of 57 | 36% |
| P/B | 1.0 | 1.4 | 23 of 59 | 60% |
| ROCE | 3.5 | 6.2 | 39 of 65 | 41% |
| ROE | 3.0 | 4.9 | 38 of 65 | 42% |
| Debt / Equity | 0.0 | 0.2 | 20 of 65 | 70% |
| EBITDA margin | 15.0 | 13.3 | 21 of 58 | 65% |
| Revenue growth | 44.1 | 6.7 | 6 of 54 | 91% |
| Profit growth | 642.3 | 21.0 | 5 of 64 | 94% |
| Market cap | 362 | 77 | 25 of 65 | 63% |
| an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
